AAO 2024 Insights
- Retina & Vitreous
- Uveitis
- Cornea & External Disease
- Cataract & Lens
- Oculoplastics
- Pediatric & Strabismus
- Glaucoma
- Neuro-Ophthalmology
- Business

Video Player is loading.
Current Time 0:00
/
Duration 0:00
Loaded: 0%
0:00
Stream Type LIVE
1x
- 0.5x
- 0.75x
- 1x, selected
- 1.25x
- 1.5x
- 1.75x
- 2x
- Chapters
- descriptions off, selected
- captions settings, opens captions settings dialog
- captions off, selected
This is a modal window.
Beginning of dialog window. Escape will cancel and close the window.
End of dialog window.
10 seconds
Playback speed
This is a modal window. This modal can be closed by pressing the Escape key or activating the close button.
AAO 2024 Insights: Aflibercept 8 mg for Diabetic Macular Edema - Week 96 Efficacy Outcomes by Baseline Characteristics in the PHOTON Trial
By
AAO 2024 Insights
FEATURING
Sean Adrean
By
AAO 2024 Insights
FEATURING
Sean Adrean
183 views
October 23, 2024
Comments 0
Login to view comments.
Click here to Login
Retina & Vitreous